Literature DB >> 9416436

Proposed criteria for the diagnosis of diabetes: evidence from a French epidemiological study (D.E.S.I.R.).

B Balkau1, E Eschwege, J Tichet, M Marre.   

Abstract

The American Diabetes Association and a working group of the International Diabetes Federation and the World Health Organisation are considering the possibility of lowering the level of fasting glucose for diagnosis of diabetes from 7.8 mM to 7.0 mM (126 mg/dl) and adding a "hyperglycaemia" category (6.1-6.9 mM). This report studied the resulting change in the frequency of diabetes in the French D.E.S.I.R. cohort and evaluated cardiovascular risk factors according to the proposed limits. The frequency of treated diabetes was 1.0% in this cohort of more than 5,000 French men and women 30 to 64 years of age, 0.7% had a fasting glucose > or = 7.8 mM versus 1.6% for the proposed > or = 7.0 mM. Using the new criteria, 3.8% of men and 1.6% of women would be diabetic. For many cardiovascular risk factors, men with fasting glucose > or = 7.8 mM had a significantly higher risk than those in the (7.0-7.7 mM) range, whereas no significant differences were found for women. There were few differences between the (7.0-7.7 mM) and (6.1-6.9 mM) ranges, but highly significant differences were apparent for both sexes between the normoglycaemic (< 6.1 mM) and hyperglycaemic (6.1-6.9 mM) categories. The percentage of men with two or more of ten risk factors increased with fasting glucose: 36% in the normoglycaemic (< 6.1 mM) and 49% in the hyperglycaemic (6.1-6.9 mM) categories; 73% with fasting glucose in (7.0-7.7 mM) versus 90% with fasting glucose > or = 7.8 mM. In women, the corresponding percentages were lower: 26% and 60%, 32% versus 64% respectively. The major increase in cardiovascular risk factors would appear to occur at 6.1 mM, for men, whereas the increase in the combination of risk factors was at the more conservative cut-off of 7.0 mM.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9416436

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  14 in total

1.  Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study.

Authors:  Stéphane Cauchi; Christine Proença; Hélène Choquet; Stefan Gaget; Franck De Graeve; Michel Marre; Beverley Balkau; Jean Tichet; David Meyre; Martine Vaxillaire; Philippe Froguel
Journal:  J Mol Med (Berl)       Date:  2008-01-22       Impact factor: 4.599

2.  Combined effects of MC4R and FTO common genetic variants on obesity in European general populations.

Authors:  Stéphane Cauchi; Fanny Stutzmann; Christine Cavalcanti-Proença; Emmanuelle Durand; Anneli Pouta; Anna-Liisa Hartikainen; Michel Marre; Sylviane Vol; Tuija Tammelin; Jaana Laitinen; Arturo Gonzalez-Izquierdo; Alexandra I F Blakemore; Paul Elliott; David Meyre; Beverley Balkau; Marjo-Riitta Järvelin; Philippe Froguel
Journal:  J Mol Med (Berl)       Date:  2009-03-03       Impact factor: 4.599

3.  Novel association approach for variable number tandem repeats (VNTRs) identifies DOCK5 as a susceptibility gene for severe obesity.

Authors:  Julia S El-Sayed Moustafa; Hariklia Eleftherohorinou; Adam J de Smith; Johanna C Andersson-Assarsson; Alexessander Couto Alves; Eleni Hadjigeorgiou; Robin G Walters; Julian E Asher; Leonardo Bottolo; Jessica L Buxton; Rob Sladek; David Meyre; Christian Dina; Sophie Visvikis-Siest; Peter Jacobson; Lars Sjöström; Lena M S Carlsson; Andrew Walley; Mario Falchi; Philippe Froguel; Alexandra I F Blakemore; Lachlan J M Coin
Journal:  Hum Mol Genet       Date:  2012-05-16       Impact factor: 6.150

4.  Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study.

Authors:  Pascale Massin; Céline Lange; Jean Tichet; Sylviane Vol; Ali Erginay; Martine Cailleau; Eveline Eschwège; Beverley Balkau
Journal:  Arch Ophthalmol       Date:  2011-02

5.  Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study.

Authors:  Beverley Balkau; Celine Lange; Sylviane Vol; Frederic Fumeron; Fabrice Bonnet
Journal:  BMC Gastroenterol       Date:  2010-06-07       Impact factor: 3.067

6.  A new highly penetrant form of obesity due to deletions on chromosome 16p11.2.

Authors:  R G Walters; S Jacquemont; A Valsesia; A J de Smith; D Martinet; J Andersson; M Falchi; F Chen; J Andrieux; S Lobbens; B Delobel; F Stutzmann; J S El-Sayed Moustafa; J-C Chèvre; C Lecoeur; V Vatin; S Bouquillon; J L Buxton; O Boute; M Holder-Espinasse; J-M Cuisset; M-P Lemaitre; A-E Ambresin; A Brioschi; M Gaillard; V Giusti; F Fellmann; A Ferrarini; N Hadjikhani; D Campion; A Guilmatre; A Goldenberg; N Calmels; J-L Mandel; C Le Caignec; A David; B Isidor; M-P Cordier; S Dupuis-Girod; A Labalme; D Sanlaville; M Béri-Dexheimer; P Jonveaux; B Leheup; K Ounap; E G Bochukova; E Henning; J Keogh; R J Ellis; K D Macdermot; M M van Haelst; C Vincent-Delorme; G Plessis; R Touraine; A Philippe; V Malan; M Mathieu-Dramard; J Chiesa; B Blaumeiser; R F Kooy; R Caiazzo; M Pigeyre; B Balkau; R Sladek; S Bergmann; V Mooser; D Waterworth; A Reymond; P Vollenweider; G Waeber; A Kurg; P Palta; T Esko; A Metspalu; M Nelis; P Elliott; A-L Hartikainen; M I McCarthy; L Peltonen; L Carlsson; P Jacobson; L Sjöström; N Huang; M E Hurles; S O'Rahilly; I S Farooqi; K Männik; M-R Jarvelin; F Pattou; D Meyre; A J Walley; L J M Coin; A I F Blakemore; P Froguel; J S Beckmann
Journal:  Nature       Date:  2010-02-04       Impact factor: 49.962

7.  Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study.

Authors:  Benedicte Fontaine-Bisson; Marie-Christine Alessi; Noemie Saut; Frederic Fumeron; Michel Marre; Anne Dutour; Catherine Badens; Nicolas Levy; Jean Tichet; Irene Juhan-Vague; David-Alexandre Trégouët; Beverly Balkau; Pierre-Emmanuel Morange
Journal:  J Mol Med (Berl)       Date:  2009-10-16       Impact factor: 4.599

8.  Waist circumference and obesity-related abnormalities in French and Cameroonian adults: the role of urbanization and ethnicity.

Authors:  L Fezeu; B Balkau; E Sobngwi; A-P Kengne; S Vol; P Ducimetiere; J-C Mbanya
Journal:  Int J Obes (Lond)       Date:  2010-01-12       Impact factor: 5.095

9.  Type 2 diabetes-related genetic risk scores associated with variations in fasting plasma glucose and development of impaired glucose homeostasis in the prospective DESIR study.

Authors:  Martine Vaxillaire; Loïc Yengo; Stéphane Lobbens; Ghislain Rocheleau; Elodie Eury; Olivier Lantieri; Michel Marre; Beverley Balkau; Amélie Bonnefond; Philippe Froguel
Journal:  Diabetologia       Date:  2014-06-04       Impact factor: 10.122

10.  The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.

Authors:  Martine Vaxillaire; Christine Cavalcanti-Proença; Aurélie Dechaume; Jean Tichet; Michel Marre; Beverley Balkau; Philippe Froguel
Journal:  Diabetes       Date:  2008-06-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.